CALL FOR PAPERS

CERTIFICATE

IMPACT FACTOR 2019

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

 

 

 

Clinico-pathological features of differentiatedthyroid cancer and their impactson prognosis

Author: 
Khaled Abdul Karim, Ali L Ahmed and Khaled N Abdelhakim
Subject Area: 
Health Sciences
Abstract: 

Background: Differentiated thyroid cancer (DTC) is the most common type of thyroid cancer, with increasing incidence in last years, especially in female with three to four times in female comparing to male, also the relative increasing incidence of DTC in the mulitnodular goiter which was clearly observed in this study. Aim of the Work: This is a retrospective study which aims to analyze the clinical and pathological features of DTC and their impacts on the prognosis for patients with differentiated thyroid cancer who attended the Department of Clinical Oncology and Nuclear medicine in Ain Shams University Hospital between the years (2011-2016).Subjects and Methods: Data were collected and analyzed retrospectively from the files of the patients with DTC between the years (2011-2016), who attended the Clinical Oncology and Nuclear Medicine Department of Ain Shams University Hospital, Cairo – Egypt. Out of 102 patients with DTC, 21 patients were excluded due to insufficient data and loss of follow up, results obtained from 81 patients who were followed up until the end point of study. The mean period of follow up was 39.85±18.28 months. Results and Conclusion: The tumor size, lymph node metastases, capsular invasion, stage and grade were most important histopathological prognostic factors in relation to relapse risk, while the role of tumor multifocality and LVI were Insignificant. The role of different ablative doses of RAI131 was not significant in relation to risk of relapse in DTC patients. Recommendations: The use of proper risk stratification system by reassessing of relapse risk using the level of serum Tg and results of follow-up diagnostic images as markers of the response to initial surgery and radioactive iodine (RAI) remnant ablation. Further studies with larger number populations are needed to confirm the results obtained by the current work and to evaluate the role of gene mutations and other molecular markers which may affect the prognosis of DTC.

PDF file: 

Announcement

IJMCE RECOMMENDATION

ONLINE PAYPAL PAYMENT

CURRENT ISSUE

NEWS

CHIEF EDITOR
Rosane Cavalcante Fragoso, Brasil
ASSOCIATE CHIEF EDITOR

   

Jean-Marc SABATIER
Chief Scientific Officer and Head of a Research Group
France

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

EDITORIAL BOARD

Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran